Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001144204-17-021329

President and CEO acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CARUSO JAMES V President and CEO 2017-04-18 Grant or award +200,000 247,548 D
Loading xslF345X03/v464724_form4.xml…